These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8304132)

  • 41. [Quantitative measurement of brain metabolism by positron CT].
    Shinotoh H; Tateno Y
    Nihon Rinsho; 1985 Feb; 43(2):329-33. PubMed ID: 2987568
    [No Abstract]   [Full Text] [Related]  

  • 42. [Regional distribution of the muscarinic cholinergic receptor in the human brain studied with 11C-benztropine and PET using an anatomical standardization technique].
    Ono S; Kawashima R; Ito H; Koyama M; Goto R; Inoue K; Sato K; Fujiwara T; Meguro K; Yanai K; Sasaki H; Ido T; Ito M; Fukuda H
    Kaku Igaku; 1996 Jul; 33(7):721-7. PubMed ID: 8803440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: control and competition studies.
    Carson RE; Kiesewetter DO; Jagoda E; Der MG; Herscovitch P; Eckelman WC
    J Cereb Blood Flow Metab; 1998 Oct; 18(10):1130-42. PubMed ID: 9778190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter.
    Ding YS; Fowler JS; Logan J; Wang GJ; Telang F; Garza V; Biegon A; Pareto D; Rooney W; Shea C; Alexoff D; Volkow ND; Vocci F
    Synapse; 2004 Sep; 53(3):184-9. PubMed ID: 15236351
    [No Abstract]   [Full Text] [Related]  

  • 45. Generalized decrease in brain glucose metabolism during fasting in humans studied by PET.
    Redies C; Hoffer LJ; Beil C; Marliss EB; Evans AC; Lariviere F; Marrett S; Meyer E; Diksic M; Gjedde A
    Am J Physiol; 1989 Jun; 256(6 Pt 1):E805-10. PubMed ID: 2786677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anxiety levels in dreams: relation to localized cerebral glucose metabolic rate.
    Gottschalk LA; Buchsbaum MS; Gillin JC; Wu JC; Reynolds CA; Herrera DB
    Brain Res; 1991 Jan; 538(1):107-10. PubMed ID: 2018922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment: positron emission tomography. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 1991 Feb; 41(2 ( Pt 1)):163-7. PubMed ID: 1992357
    [No Abstract]   [Full Text] [Related]  

  • 48. Dynamic monitoring of [11C]diprenorphine in rat brain using a prototype positron imaging device.
    Rajeswaran S; Hume SP; Cremer JE; Young J; Bailey DL; Ashburner J; Luthra SK; Jones AK; Jones T
    J Neurosci Methods; 1991 Dec; 40(2-3):223-32. PubMed ID: 1800857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
    Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
    Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiotracers for functional brain imaging.
    Blau M
    Semin Nucl Med; 1985 Oct; 15(4):329-34. PubMed ID: 3904003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
    Tamminga CA
    Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
    [No Abstract]   [Full Text] [Related]  

  • 52. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET with fluorine-18 deoxyglucose for pancreatic disease.
    Klever P; Bares R; Fass J; Büll U; Schumpelick V
    Lancet; 1992 Nov; 340(8828):1158-9. PubMed ID: 1359226
    [No Abstract]   [Full Text] [Related]  

  • 54. Special characteristics and potential for radiotracers for positron emission tomography.
    Fowler JS; Wolf AP
    Acupunct Electrother Res; 1981; 6(2-3):81-108. PubMed ID: 6120624
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat.
    Zhang X; Tian JY; Svensson AL; Gong ZH; Meyerson B; Nordberg A
    J Neural Transm (Vienna); 2002 Mar; 109(3):377-92. PubMed ID: 11956958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PET, MRI, and epilepsy.
    Arroyo S; Lesser RP
    Neurology; 1993 Oct; 43(10):2156. PubMed ID: 8280264
    [No Abstract]   [Full Text] [Related]  

  • 57. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
    Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ
    J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography.
    Maziere M
    Pharmacol Ther; 1995 Apr; 66(1):83-101. PubMed ID: 7630931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.
    Iida Y; Ogawa M; Ueda M; Tominaga A; Kawashima H; Magata Y; Nishiyama S; Tsukada H; Mukai T; Saji H
    J Nucl Med; 2004 May; 45(5):878-84. PubMed ID: 15136639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication.
    Baron JC; Lebrun-Grandie P; Collard P; Crouzel C; Mestelan G; Bousser MG
    J Nucl Med; 1982 May; 23(5):391-9. PubMed ID: 6978932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.